Literature DB >> 12120990

Antigenic diversity of Encephalitozoon hellem demonstrated by subspecies-specific monoclonal antibodies.

Lan Mo1, Michel Drancourt.   

Abstract

Encephalitozoon hellem is a unicellular, obligate intracellular microsporidian species detected and isolated in HIV-infected patients presenting with keratoconjunctivitis, sinusitis, tracheobronchitis, nephritis, cystitis, and disseminated infection. A total of 24 monoclonal antibodies were produced against E. hellem and characterized. The monoclonal antibodies were of the immunoglobulin (Ig) G and Ig M subclasses, and, when incorporated into indirect immunofluorescence and immunoblotting assays, reacted against 13 isolates of E. hellem originating from three geographic regions. These monoclonal antibodies did not react with one strain each of either Encephalitozoon intestinalis or Encephalitozoon cuniculi, demonstrating their specificity. Two monoclonal antibodies reacted with all karyotype B-E. hellem isolates but did not react with karyotype A-isolates from North America and the Netherlands, thus demonstrating antigenic diversity among E. hellem isolates. These results add to the increasing evidence for diversity among E. hellem, which therefore may be reclassified into subspecies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12120990     DOI: 10.1111/j.1550-7408.2002.tb00531.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  2 in total

1.  Monoclonal antibodies for specific detection of Encephalitozoon cuniculi.

Authors:  Lan Mo; Michel Drancourt
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Production and characterization of monoclonal antibodies against Encephalitozoon intestinalis and Encephalitozoon sp. spores and their developmental stages.

Authors:  Fernando Izquierdo; Hercules Moura; Fernando Jorge Bornay-Llinares; Rama Sriram; Carolina Hurtado; Ángela Magnet; Soledad Fenoy; Govinda Visvesvara; Carmen Del Aguila
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.